Cullinan Therapeutics, Inc. (CGEM) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $39.64M | +25.9% |
| 2024 | $31.50M | +4.0% |
| 2023 | $30.29M | +16.1% |
| 2022 | $26.09M | +120.9% |
| 2021 | $11.81M | -17.9% |
| 2020 | $14.39M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $39.64M | +25.9% |
| 2024 | $31.50M | +4.0% |
| 2023 | $30.29M | +16.1% |
| 2022 | $26.09M | +120.9% |
| 2021 | $11.81M | -17.9% |
| 2020 | $14.39M | — |